-20 % Change Amount % Amount % Amount % Q3-20 VS Q3-19 Q3-20 VS Q2-20 Sales revenue 17,540 100.0 12,404 100.0 14,491 100.0 41.4 21.0 Gross profit 4,574 26.1 2,373 19.1 3,892 26.9 92.8 17.5 Operating

% Change Amount % Amount % Amount % Q1-21 VS Q1-20 Q1-21 VS Q4-20 Sales revenue 19,039 100.0 12,755 100.0 18,498 100.0 49.3 2.9 Gross profit 4,103 21.6 2,586 20.3 4,067 22.0 58.7 0.9 Operating profit 1,372

Summary Significant Event & Business Overview Operating Highlights in Q3/2024 Q3/23 Q3/24 Change +/(-) 9M/23 9M/24 Change +/(-) (THB million) %YoY %YoY Operating Revenue 338 428 27% 900 1,144 27% Gross

growth was attributed by the increase of number of patients as well as bill amount per patient . Revenues for the year 2018 increased 13% yoy which were contributed by both non-social security and social

- 2019 Balance by Quarter Change Q1–19 Q4–18 Q1–18 Q1–19 VS Q4–18 Q1–19 VS Q1–18 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,266.5 1,109.5 1,044.9 157.0 14.2 221.6 21.2 Total Operating Expenses

Baht 207 million and gross profit margin for the second quarter of 2019 was 24%. There was no significant change compared to the same period of the previous year. Q2’ 2019 Q2’ 2018 Increase (decrease

2019, the company and its subsidiaries’ construction income was Baht 44.36 million, whereas Baht 35.57 million in 2018, showing an increase of Baht 8.79 million or representing 24.71 % increase. Overall

) operating results based on its reviewed consolidated financial statements ended 30 September 2018 as follows. Highlights on Q3-2018 Operating results Unit : Million Baht Q3-18 Q3-17 Q2-18 % Change Amount

223,900 80,751 22,292 20,512 28,222 Change (25,507) (8,341) 783 2,010 (4,514) % Change (10.23%) (9.36%) 3.64% 10.86% (13.79%) In overall, the Company and its subsidiaries had a net profit in Q3/ 2019 of 28

2017 Change Reason Liquidity Ratio (x) 5.28 6.80 (1.52) The increase in accounts payable and other payable. Quick Ratio (x) 1.88 3.47 (1.59) Return on Equity (%) 3.19 5.83 (2.64) The decrease in 9M18 net